Search Results
Sep 02, 2026, 07:54 ET Bayesian Health's FDA-Cleared Continuous AI Sepsis Monitor Approved for Medicare New Technology Add-on Payment (NTAP)
2026 /PRNewswire/ -- Bayesian Health today announced that its FDA-cleared sepsis flagging device has been approved for a New Technology Add-on Payment (NTAP) under the Centers for Medicare and Medicaid Services' FY 2027 Inpatient Prospective Payment System Final Rule. Beginning October 1, 2026, hospitals
More news about: Bayesian Health
Aug 19, 2026, 08:30 ET Renata Medical Closes $25M Series D Financing Led by Global Healthcare Investment Firm ARCHIMED to Accelerate Commercialization and Development of Pediatric Cardiovascular Technologies
approval in August 2024. In August 2025, the Centers for Medicare & Medicaid Services (CMS) granted the device a New Technology Add-on Payment (NTAP) designation, providing hospitals with additional reimbursement support for the technology."Children born with congenital heart defects have
More news about: Renata Medical
Aug 13, 2026, 09:00 ET Aidoc's CARE Body CT Multi-Triage receives eligibility for Medicare New Technology Add-on Payment
Technology Add-on Payment (NTAP) for the CARE™ Multi-Triage CT Body device1, providing a Medicare Fee For Service add-on payment for eligible inpatient use of the FDA-cleared AI technology in analyzing and triaging patient cases with a broad set of acute findings. The NTAP program facilitates Medicare
More news about: Aidoc
Jun 25, 2026, 15:00 ET Alger Russell Innovation Index Updates for Second Quarter 2026
NetApp Inc.NTAPDeletion
More news about: Alger
Jun 22, 2026, 16:30 ET Alger Russell Innovation Index Updates for Second Quarter 2026
NetApp Inc.NTAPDeletion
More news about: Alger
Jun 22, 2026, 06:30 ET CGI and NetApp deepen global alliance to drive innovation, accelerate growth and strengthen client outcomes
MONTRÉAL and SAN JOSE, Calif., June 22, 2026 /PRNewswire/ - CGI (TSX: GIB.A) (NYSE: GIB) and NetApp (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced that NetApp Keystone will power CGI's block storage solutions within its shared services
More news about: CGI Inc.
May 12, 2026, 06:00 ET Bayesian Health Receives First-Ever FDA Clearance for Continuous AI Sepsis Monitoring
Health favorably to receive approval under the Centers for Medicare and Medicaid Services' New Technology Add-on Payment (NTAP) program starting in October 2026. The final decision on NTAP approval will be issued early August. If approved as expected, this would give hospitals deploying the cleared sepsis
More news about: Bayesian Health
Apr 17, 2026, 09:00 ET The $240 Billion Race to Rebuild Cybersecurity Before Quantum Arrives
threat detection: Quantum Secure Encryption Corp. (CSE: QSE) (OTCQB: QSEGF) (FSE: VN8), Commvault (NASDAQ: CVLT), NetApp (NASDAQ: NTAP), Zscaler (NASDAQ: ZS), and F5 (NASDAQ: FFIV).
More news about: Equity Insider
Mar 27, 2026, 08:09 ET Sonorous NV, Inc. Announces Leadership Transition
FDA Breakthrough Device Designation for treating pulse-synchronous tinnitus due to venous sinus stenosis, enabling prioritized review and potential NTAP eligibility.Sonorous is advancing toward IDE submission and broader market approvals.Sonorous Neurovascular remains committed
More news about: Sonorous NV, Inc.
Mar 11, 2026, 08:30 ET FDA Grants Breakthrough Device Designation to MeMed BV Flex™ Capillary Blood
interactive FDA engagement, accelerating development and regulatory review. In addition, BDD provides eligibility to Medicare's New Technology Add-on Payment (NTAP) alternative pathway and Transitional Coverage for Emerging Technologies (TCET). These programs may support broader Medicare coverage, strengthening
More news about: MeMed
Dec 03, 2025, 12:29 ET MiRus Announces First Cases with EUROPA® Posterior Cervical Fusion System with New Technology Add-on Payment (NTAP)
rhenium alloys, for treatment of the cervical and upper thoracic spine. The EUROPA® PCF system had received New Technology Add-on Payment (NTAP) from CMS earlier this year.
More news about: MiRus
Dec 03, 2025, 09:23 ET Natus announces FDA 510(k) clearance for electrographic status epilepticus diagnostic indication in BrainWatch point-of-care EEG solution
BrainWatch solution now includes electrographic status epilepticus monitoring technology, which is eligible for a New Technology Add-on Payment, or NTAP. BrainWatch will be on display Dec. 6-8 during the American Epilepsy Society annual meeting in Atlanta. Visitors to the Natus booth can learn more about
More news about: Natus Medical Incorporated
Oct 01, 2025, 10:15 ET New ICD-10-PCS Code Available for AI Sepsis Diagnostic Tools
New Technology Add-on Payment (NTAP) submission processes. "This official code recognition validates the clinical significance of advanced sepsis diagnostics
More news about: Prenosis
Oct 01, 2025, 08:00 ET Airspace Link Receives FAA NTAP Approval as UTM Provider for BVLOS Strategic Deconfliction Services
FAA Near-Term Approval Process (NTAP) Positions Cities, Federal Installations, and Commercial Operators for Proposed Part 108 Implementation DETROIT, Oct.
More news about: Airspace Link